论文部分内容阅读
回顾性分析２４例肝癌术后患者临床资料和介入治疗效果，认为大部分复发系由手术时癌肿残留所致。１年内复发者占７９．１７％，２年内占８．３３％，３年内占８．３３％，３年以上者占４．１７％。术后定期复查ＡＦＰ和Ｂ超是监测早期复发的最佳方法。血管造影既能准确定位，又能了解复发病灶的血供情况，为治疗提供参考。复发患者介入治疗后１、２、３年生存率分别是８０％、４８％、１８％、。我们认为介入治疗对肝癌术后复发是有效的，早期发现和及时治疗是提高生存率的关键。
Retrospective analysis of 24 cases of liver cancer patients after clinical data and interventional treatment effect, that most of the recurrence of cancer caused by residual surgery. Recurrences accounted for 79.17% within one year, 8.33% within two years, 8.33% within three years, and 4.17% for over three years. Regular follow-up of AFP and B ultrasound is the best way to monitor early recurrence. Angiography can not only accurately locate, but also understand the blood supply of recurrent lesions, providing a reference for treatment. The 1-, 2-, and 3-year survival rates of relapsed patients after interventional therapy were 80%, 48%, and 18%, respectively. We believe that interventional treatment is effective for the recurrence of liver cancer, early detection and timely treatment are the key to improve survival.